Dalbavancin for the Treatment of Prosthetic Joint Infections: A Narrative Review

• Main Authors: Luis Buzón-Martín (Author), Ines Zollner-Schwetz (Author), Selma Tobudic (Author), Emilia Cercenado (Author), Jaime Lora-Tamayo (Author)
• Format: Book
• Published: MDPI AG, 2021-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Dalbavancin (DAL) is a lipoglycopeptide with bactericidal activity against a very wide range of Gram-positive microorganisms. It also has unique pharmacokinetic properties, namely a prolonged half-life (around 181 h), which allows a convenient weekly dosing regimen, and good diffusion in bone tissue...